Tuber Pharma Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.18 M
- Company Age 49 Year, 11 Months
- Open Charges ₹ 9.64 M
About Tuber Pharma Chemicals
Tuber Pharma Chemicals Ltd (TPCL) is a Public Limited Indian Non-Government Company incorporated in India on 18 March 1975 and has a history of 49 years and 11 months. Its registered office is in Madras, Tamil Nadu.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹9.64 M.
Company Details
- Location Madras, Tamil Nadu
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TN1975PLC006883
- Company No.
006883
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Mar 1975
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Tuber Pharma Chemicals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Tuber Pharma Chemicals.
Enhance accessibility to Tuber Pharma Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tuber Pharma Chemicals?
Unlock access to Tuber Pharma Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹9.64 M
₹0
Charges Breakdown by Lending Institutions
- The Tamilnadu Industrial Investment Corporation Ltd. : 0.86 Cr
- Indian Overseas Bank : 0.08 Cr
- The Lakshmi Vilas Bank Ltd. : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 1985 | Indian Overseas Bank | ₹0.50 M | Open |
| 15 Nov 1985 | Indian Overseas Bank | ₹0.15 M | Open |
| 26 Apr 1979 | Indian Overseas Bank | ₹0.15 M | Open |
| 06 Jun 1978 | The Lakshmi Vilas Bank Ltd. | ₹0.20 M | Open |
| 30 Mar 1977 | The Tamilnadu Industrial Investment Corporation Ltd. | ₹2.88 M | Open |
How Many Employees Work at Tuber Pharma Chemicals?
Unlock and access historical data on people associated with Tuber Pharma Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tuber Pharma Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tuber Pharma Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.